Ulimorelin - Lyric Pharmaceuticals
Alternative Names: LP 101; TZP-101; Ulimorelin hydrochlorideLatest Information Update: 19 Feb 2021
At a glance
- Originator Tranzyme
- Developer Lyric Pharmaceuticals; Norgine; Tranzyme Pharma
- Class Macrocyclic compounds; Small molecules
- Mechanism of Action Ghrelin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Nutrition disorders
- Discontinued Cachexia; Digestive system disorders; Gastroparesis; Postoperative ileus
Most Recent Events
- 19 Feb 2021 No development reported - Phase-II for Nutrition disorders in Canada (IV)
- 19 Feb 2021 No development reported - Phase-II for Nutrition disorders in Netherlands (IV)
- 19 Feb 2021 No development reported - Phase-II for Nutrition disorders in Spain (IV)